{"title":"COVID-19肺炎与非COVID-19非典型肺炎的临床及影像学鉴别","authors":"O. Turan","doi":"10.14744/ejp.2022.2008","DOIUrl":null,"url":null,"abstract":"BACKGROUND AND AIM: Atypical pneumonia involves viral and some bacterial microorganisms in etiology. As Coronavirus 2019 (COVID-19) is newly identified, the differences between coronavirus and other microorganisms causing atypical pneumonia have not been fully expressed yet. We aimed to make a clinical comparison of cases with COVID-19 and atypical pneumonia. METHODS: \"Non-COVID-19 atypical pneumonia\" (non-COVID) group included patients with both radiological and clinical confirmation of atypical pneumonia by radiologists and clinicians. Patients with a positive polymerase chain reaction test formed \"COVID-19 pneumonia\" (COVID) group. Demographics, radiological, laboratory, and clinical features were recorded retrospectively. RESULTS: A total of 177 patients (46 non-COVID and 131 COVID) were included. The mean age of the COVID group was significantly lower (p=0.040). Ground-glass density and peripheral involvement were more common in thoracic computed tomography of patients with COVID-19 (p=0.017 and p=0.019). Fever and fatigue in COVID (p<0.001 and p=0.040) and shortness of breath and gastrointestinal complaints in non-COVID group were significantly higher as presenting symptoms (p<0.001 and p=0.031). In biochemical tests, impairment in liver function tests in COVID-19 (p<0.001), impairment in kidney function tests, increased C-reactive protein (CRP) and procalcitonin (PCT) in non-COVID-19 patients were more common (p=0.003, p=0.042, and p=0.023, respectively). Serum PCT, CRP, and lymphocyte levels were significantly lower in cases with COVID-19 (p<0.001, p=0.048, and p=0.016). There was no significant difference in the prognosis of both groups (p=0.556). CONCLUSIONS: With COVID-19 pandemic, there has been an increase in atypical pneumonia cases in which viral strains play a role. Symptomatic, laboratory, and radiological differences between two groups detected in our study may help in differential diagnosis especially in winter when atypical pneumonia is more common.","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"50 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical and Radiological Differentiation of COVID-19 Pneumonia from Non-COVID Atypical Pneumonia\",\"authors\":\"O. Turan\",\"doi\":\"10.14744/ejp.2022.2008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND AND AIM: Atypical pneumonia involves viral and some bacterial microorganisms in etiology. As Coronavirus 2019 (COVID-19) is newly identified, the differences between coronavirus and other microorganisms causing atypical pneumonia have not been fully expressed yet. We aimed to make a clinical comparison of cases with COVID-19 and atypical pneumonia. METHODS: \\\"Non-COVID-19 atypical pneumonia\\\" (non-COVID) group included patients with both radiological and clinical confirmation of atypical pneumonia by radiologists and clinicians. Patients with a positive polymerase chain reaction test formed \\\"COVID-19 pneumonia\\\" (COVID) group. Demographics, radiological, laboratory, and clinical features were recorded retrospectively. RESULTS: A total of 177 patients (46 non-COVID and 131 COVID) were included. The mean age of the COVID group was significantly lower (p=0.040). Ground-glass density and peripheral involvement were more common in thoracic computed tomography of patients with COVID-19 (p=0.017 and p=0.019). Fever and fatigue in COVID (p<0.001 and p=0.040) and shortness of breath and gastrointestinal complaints in non-COVID group were significantly higher as presenting symptoms (p<0.001 and p=0.031). In biochemical tests, impairment in liver function tests in COVID-19 (p<0.001), impairment in kidney function tests, increased C-reactive protein (CRP) and procalcitonin (PCT) in non-COVID-19 patients were more common (p=0.003, p=0.042, and p=0.023, respectively). Serum PCT, CRP, and lymphocyte levels were significantly lower in cases with COVID-19 (p<0.001, p=0.048, and p=0.016). There was no significant difference in the prognosis of both groups (p=0.556). CONCLUSIONS: With COVID-19 pandemic, there has been an increase in atypical pneumonia cases in which viral strains play a role. Symptomatic, laboratory, and radiological differences between two groups detected in our study may help in differential diagnosis especially in winter when atypical pneumonia is more common.\",\"PeriodicalId\":42933,\"journal\":{\"name\":\"Eurasian Journal of Pulmonology\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eurasian Journal of Pulmonology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14744/ejp.2022.2008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Pulmonology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejp.2022.2008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Clinical and Radiological Differentiation of COVID-19 Pneumonia from Non-COVID Atypical Pneumonia
BACKGROUND AND AIM: Atypical pneumonia involves viral and some bacterial microorganisms in etiology. As Coronavirus 2019 (COVID-19) is newly identified, the differences between coronavirus and other microorganisms causing atypical pneumonia have not been fully expressed yet. We aimed to make a clinical comparison of cases with COVID-19 and atypical pneumonia. METHODS: "Non-COVID-19 atypical pneumonia" (non-COVID) group included patients with both radiological and clinical confirmation of atypical pneumonia by radiologists and clinicians. Patients with a positive polymerase chain reaction test formed "COVID-19 pneumonia" (COVID) group. Demographics, radiological, laboratory, and clinical features were recorded retrospectively. RESULTS: A total of 177 patients (46 non-COVID and 131 COVID) were included. The mean age of the COVID group was significantly lower (p=0.040). Ground-glass density and peripheral involvement were more common in thoracic computed tomography of patients with COVID-19 (p=0.017 and p=0.019). Fever and fatigue in COVID (p<0.001 and p=0.040) and shortness of breath and gastrointestinal complaints in non-COVID group were significantly higher as presenting symptoms (p<0.001 and p=0.031). In biochemical tests, impairment in liver function tests in COVID-19 (p<0.001), impairment in kidney function tests, increased C-reactive protein (CRP) and procalcitonin (PCT) in non-COVID-19 patients were more common (p=0.003, p=0.042, and p=0.023, respectively). Serum PCT, CRP, and lymphocyte levels were significantly lower in cases with COVID-19 (p<0.001, p=0.048, and p=0.016). There was no significant difference in the prognosis of both groups (p=0.556). CONCLUSIONS: With COVID-19 pandemic, there has been an increase in atypical pneumonia cases in which viral strains play a role. Symptomatic, laboratory, and radiological differences between two groups detected in our study may help in differential diagnosis especially in winter when atypical pneumonia is more common.